Search
for
Sort by
Research 151–180 of 915
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Development and evaluation of novel rodent model of PCOS mimicking clinical phenotype in human disease
- Empagliflozin targeting STAT3/Akt/Nrf2 axis promoting diabetic wound healing in rat model
- Treatment options for polycystic ovary syndrome
- The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies
- New Perspectives on Nutraceutical Insulin Sensitizing Agents in the Treatment of Psoriasis and Other Dermatological Diseases
- Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatmentstill long time to reach clinical arena: a narrative review
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Advanced polymer hydrogels that promote diabetic ulcer healing: mechanisms, classifications, and medical applications
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
- Metabolic syndrome and dermatological diseases: association and treatment
- Diagnosis, Pathogenesis and Management of Polycystic Ovary Syndrome
- Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome
- Cutaneous manifestations of endocrine diseases in children
- Association Between Chlamydia trachomatis and Helicobacter pylori with Inflammation in Polycystic Ovary Syndrome: A Cross-Sectional Study
- Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease
- The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
- Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Lipid profile in androgenetic alopecia
- Cantú Syndrome Is Caused by Mutations in ABCC9
- Mineral Malnutrition Following Bariatric Surgery
- Novel mutations of the ABCA12, KRT1 and ST14 genes in three unrelated newborns showing congenital ichthyosis